A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study-Reference-Cited by-同舟云学术

A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study

Published:2005-07 Issue:1 Volume:181 Page:93-100
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Cooper Jackie A.,Miller George J.,Humphries Steve E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–97.

2. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study;Assman;Circulation,2002

3. Comparison of novel haemostatic factors and conventional risk factors for prediction of coronary heart disease;Cooper;Circulation,2000

4. Increased activation of the haemostatic system in men at high risk for fatal coronary heart disease;Miller;Thromb Haemost,1996

5. Non-fasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men;Talmud;Arterioscler Thromb Vasc Biol,2002

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the impact of automatic positive airway pressure therapy on cardiovascular risk index and vascular behavior in patients with obstructive sleep apnea: a study on heterogeneity in the therapeutic response;Journal of Clinical Sleep Medicine;2024-09

2. Genetics and Ischemic Heart Disease: Should We Opt for Genetic Testing for Primary Prevention?;Pakistan Heart Journal;2023-09-30

3. Inclisiran—A Revolutionary Addition to a Cholesterol-Lowering Therapy;International Journal of Molecular Sciences;2023-04-06

4. Prognostic Modelling Studies of Coronary Heart Disease—A Systematic Review of Conventional and Genetic Risk Factor Studies;Journal of Cardiovascular Development and Disease;2022-09-05

5. Genetic risk and its role in primary prevention of CAD;Journal of Translational Genetics and Genomics;2022